Sunday, April 24, 2022

Day 814: Negative Efficacy Numbers

PlagueBlog apologizes for taking a spring break during an exciting week that saw the end of federal transportation mask mandates as well as a damning preprint (hosted by The Lancet) RCT meta-study showing excess mortality caused by Pfizer's mRNA vaccine. (That is, it killed more people with side effects than it saved from COVID.) The bad cat has the details:
this rush to EUA not only allowed a seriously rigged drug trial methodology to be used (ignoring or misattributing the ill effects of immuno-suppression post dose 1 and for 7 days post dose 2, both know[n] and serious issues deliberately designed out of assessment despite the fact that all those getting the jabs would experience them) but also more or less ignored the overall mortality data despite the fact that it was not only available, but unfavorable.

certain felines were heard to describe it as “not so much as a vaccine study as an instagram selfie”

it appears these danish researchers are coming around to this viewpoint as well.

this was always available data. there were few deaths in the pfizer trial overall as the enrollees were generally young and healthy. 79% had zero comorbidities.

and they clearly played some games. they called a death in the vaxx arm “covid pneumonia” to avoid having a “covid death” and excluded it when calculating VE.

there was also a significant cardiovascular risk signal. this is why more people died overall in the active arm than in placebo. in the moderna trial, overall mortality was exactly equal in the 2 arms.
It is surprising that Moderna, which is known for having more side effects from its larger dose, actually broke even in the save-grandma/kill-grandson trade-off, but even more surprising is that Johnson & Johnson, the vaccine the regulators actually pinned a few deaths on and (occasionally) regulated, was the safest and most effective of the bunch.

This must be what the kids these days mean by "clown world".

P.S. Massachusetts cases were up a seventh of a percentage point on Friday.

No comments: